# CODING_FRAMEWORK_INTEGRATION.md

## Document Information

**Document:** CODING_FRAMEWORK_INTEGRATION.md
**Project:** 12-Gene Gastric Cancer Signature — Part 2: Modernized Biomarker Discovery Framework
**Governed by:** PROJECT_GOVERNANCE_PROMPT_v4.6; FRAMEWORK_SPEC.md; IMPLEMENTATION_MASTER_PLAN.md; CODING_PHASE_PHILOSOPHY.md; IDS-003 through IDS-006; Discovery, Modeling, Validation, Interpretation, and Clinical Translation Checkpoints
**Status:** Synthesis artifact — not a Coding Module. Introduces no implementation, no governance change, no framework contract change, no API change.
**Prepared by:** Coding Agent (Claude), per `CODING_FRAMEWORK_INTEGRATION_PROMPT_SPEC.md`

---

# Section 1 — Coding Phase Summary

The Coding Phase comprised 15 Coding Modules (Module 01 through Module 15), implementing the `GCSignatureFramework` R package: the Modernized Biomarker Discovery Framework benchmarking layer for Part 2 of the project.

**Overall objective:** build a generic, domain-agnostic R package skeleton across the full biomarker-discovery lifecycle — Discovery, Modeling, Validation & Benchmark, Interpretability, and Clinical Translation — establishing stable contracts, orchestration patterns, and extensibility points, without embedding any real scientific, statistical, or clinical methodology. Real methodology (e.g. LASSO, Elastic Net, Bootstrap validation, Nested CV, Stability selection) is explicitly deferred to future, additive work via the callback mechanisms this Coding Phase establishes.

**Scope and IDS domains covered:**

| IDS | Domain | Modules |
|---|---|---|
| IDS-001 | Framework Implementation | 01–02 |
| IDS-002 | Discovery | 03–05 |
| IDS-003 | Modeling | 06–08 |
| IDS-004 | Validation & Benchmark | 09–11 |
| IDS-005 | Interpretability | 12–13 |
| IDS-006 | Clinical Translation | 14–15 |

**Implementation boundaries:** every module operated strictly within its assigned IDS responsibility; no module performed real scientific computation; no module modified a previously LOCKED module; every artifact-producing module respected the Additive-only Principle and the Stable API Principle established from Module 01 onward.

**Completion status:** all 15 Coding Modules are LOCKED. All five phase Checkpoints (Discovery, Modeling, Validation, Interpretation, Clinical Translation) have PASSED. The Coding Phase is complete. This document is the canonical synthesis produced at its conclusion.

---

# Section 2 — Overall Execution Architecture

From Module 09 onward (the Validation & Benchmark domain through the end of the Coding Phase), every domain-execution module implements the same four-stage architecture:

```
Workflow

↓

Executor

↓

Implementation Object

↓

Framework Artifact
```

**Orchestration (Workflow):** a constructor function (e.g. `create_validation_object()`, `create_benchmark_object()`, `create_interpretation_object()`) assembles an initial Implementation Object from a verified upstream Framework Artifact, consumed strictly read-only.

**Execution separation (Executor):** a single `run_*()` entry point (e.g. `run_validation()`, `run_benchmark()`, `run_clinical_output()`) orchestrates execution: it validates the Implementation Object, invokes a callback (default generic, or caller-supplied) to perform the actual execution step, and never performs computation itself. This strict separation between orchestration and execution was first established architecturally in Phase B (Module 03 = Workflow, Module 04 = Execution) and then carried forward as a unified, single-module pattern from Module 09 onward.

**Implementation state (Implementation Object):** the object returned/updated by the Executor captures consumed upstream artifacts, execution components, and execution metadata. Implementation Objects are never exposed as Framework artifacts and never cross domain boundaries.

**Framework contracts (Framework Artifact):** the Executor constructs exactly one Framework Artifact per run, via the LOCKED Module 02 `create_artifact_contract()`, embedding the complete, unmodified Implementation Object for lineage. This is the only object type that crosses a domain boundary.

This four-stage architecture was applied identically, without shortcut, across all of Modules 09–15 (Validation, Benchmark, Candidate Selection, Scientific Interpretation, Evidence Integration, Clinical Translation, Clinical Outputs) — seven consecutive modules sharing one execution architecture.

Earlier phases established structurally equivalent, if not identically named, patterns: Module 03 (Discovery Workflow) / Module 04 (Discovery Execution) for Phase B, and Module 06 (Construction) / Module 07 (Management/Execution) / Module 08 (Output Boundary) for Phase C.

No alternative architecture was introduced at any point in the Coding Phase.

---

# Section 3 — Implementation Object Hierarchy

Implementation Objects are never Framework artifacts; they are internal containers of execution state, consumed and produced entirely within a single module's responsibility.

| Implementation Object | Module | Encapsulates |
|---|---|---|
| `discovery_pipeline` | 03 | Registered stages, dependency graph, pipeline metadata |
| `model_specification` | 06 | Generic `algorithm_id` + `parameter_schema` |
| `model_contract` | 06 | Specification lineage + consumed Discovery artifact(s) |
| `model_object` | 06 | Embedded specification + contract reference (self-contained, immutable) |
| `training_object` | 07 | `trained_model` + `training_metadata` + embedded Model Object |
| `validation_object` | 09 | Consumed Model Candidate + Modeling Evidence, validation components |
| `benchmark_object` | 10 | Consumed Validation Evidence, benchmark components |
| `candidate_selection_object` | 11 | Consumed Benchmark Evidence, selection components |
| `interpretation_object` | 12 | Consumed Validated Candidate, interpretation components |
| `evidence_integration_object` | 13 | Consumed Interpretation Evidence, integration components |
| `clinical_translation_object` | 14 | Consumed Interpretation Package, translation components |
| `clinical_output_object` | 15 | Consumed Clinical Translation Evidence, output components |

**Responsibility pattern:** every Implementation Object from Module 09 onward shares an identical internal shape — a single embedded upstream artifact, a `*_components` list (initially empty, populated by the Executor's callback), an `execution_metadata` list, and a generic `metadata` list. This consistency is itself a verified design outcome (Section 8), not an a priori specification.

No Implementation Object was ever exposed across a domain boundary, and none were modified after their producing module's LOCK.

---

# Section 4 — Framework Artifact Hierarchy

Framework Artifacts are the only objects that cross domain boundaries. Every Framework Artifact in the Coding Phase is constructed via the single, LOCKED Module 02 `create_artifact_contract()` — no new Framework Contract type was introduced at any point across 15 modules.

**Complete artifact lineage (IDS-002 → IDS-006):**

```
Discovery artifact (Module 04, framework_layer = "processing")
        ↓
Model Contract / Model Object (Module 06, implementation-only)
        ↓
Training Object (Module 07, implementation-only)
        ↓
Model Candidate  +  Modeling Evidence   (Module 08)
        ↓
Validation Evidence                    (Module 09)
        ↓
Benchmark Evidence                     (Module 10)
        ↓
Validated Candidate                    (Module 11)
        ↓
Interpretation Evidence                (Module 12)
        ↓
Interpretation Package                 (Module 13)
        ↓
Clinical Translation Evidence          (Module 14)
        ↓
Clinical Translation Package           (Module 15 — terminal artifact)
```

**Downstream responsibilities at each handoff:**

| Artifact | Producer | Consumer (default) |
|---|---|---|
| Model Candidate / Modeling Evidence | Module 08 | `"validation_benchmark"` |
| Validation Evidence | Module 09 | `"benchmark"` |
| Benchmark Evidence | Module 10 | `"candidate_selection"` |
| Validated Candidate | Module 11 | `"interpretability"` |
| Interpretation Evidence | Module 12 | `"interpretation_package"` |
| Interpretation Package | Module 13 | `"clinical_translation"` |
| Clinical Translation Evidence | Module 14 | `"clinical_translation_package"` |
| Clinical Translation Package | Module 15 | `"framework_integration"` |

Every artifact preserves its complete upstream lineage by composition (embedding, never re-deriving), confirmed end-to-end by automated tests at Modules 08, 11, and 15 tracing the original Module 04 Discovery artifact through to each successive terminal artifact. No artifact in this hierarchy was ever modified after the LOCK of its producing module. No new artifact is introduced by this document.

---

# Section 5 — Callback Execution Architecture

Every Executor accepts an optional callback parameter, defaulting to an internal generic implementation, with the same contract: replace only the execution step, never bypass workflow, verification, lineage, or artifact construction.

| Callback parameter | Module | Default behavior |
|---|---|---|
| `trainer` | 07 | `.default_generic_trainer()` — structural placeholder, no algorithm |
| `validator` | 09 | `.default_generic_validator()` — `structural_check` only |
| `benchmarker` | 10 | `.default_generic_benchmarker()` — `structural_check` only |
| `selector` | 11 | `.default_generic_selector()` — `structural_check` only |
| `interpreter` | 12 | `.default_generic_interpreter()` — `structural_check` only |
| `integrator` | 13 | `.default_generic_integrator()` — `structural_check` only |
| `translator` | 14 | `.default_generic_translator()` — `structural_check` only |
| `output_generator` | 15 | `.default_generic_output_generator()` — `structural_check` only |

**Why callbacks were adopted:** the Coding Phase's explicit mandate (Zero/Generic Implementation Principle) prohibits embedding real scientific, statistical, or clinical methodology in any module. The callback pattern resolves this without leaving any module's execution step unimplemented: a generic default satisfies structural requirements (the module loads, runs, and produces a valid artifact), while the identical parameter slot is the designated extension point for real methodology in future, additive work — without requiring any change to a LOCKED function's signature or semantics.

**Generic execution:** every default callback returns exactly one named component, `structural_check`, with a `passed = TRUE` flag and a `details` string explicitly disclaiming the methodology that module's domain might eventually require (e.g. Module 10's benchmarker disclaims "ROC/AUC/survival/statistical/ML methodology"). This is independently verified, per module, by a dedicated test asserting the disclaiming text and the absence of any non-generic computation.

**Future extensibility:** because every Executor validates that the callback returns a named list (supporting Section 8's "multiple independent components" guarantee) and never inspects its contents beyond that, a future, additive module may supply real methodology as a drop-in callback argument to an already-LOCKED `run_*()` function, with zero modification to that function.

No callback type beyond the eight listed above was introduced, and none were modified after their introducing module's LOCK.

---

# Section 6 — `framework_layer` Taxonomy

`metadata$framework_layer` is the per-domain context tag attached to every Framework Artifact's `metadata`, established as a deliberate alternative to overloading `contract_type` (Module 03's Pre-Implementation Decision Record: `contract_type` is a pure contract-ontology field — `"artifact"` / `"interface"` / `"dependency"` / `"verification"` — and is never used to encode domain context).

**Complete taxonomy (six values, one per IDS domain in order of introduction):**

| `framework_layer` value | IDS domain | First introduced |
|---|---|---|
| `"discovery"` | IDS-002 (orchestration context) | Module 03 |
| `"processing"` | IDS-002 (Discovery artifact) | Module 04 |
| `"modeling"` | IDS-003 | Module 08 |
| `"validation_benchmark"` | IDS-004 | Module 09 |
| `"interpretability"` | IDS-005 | Module 12 |
| `"clinical_translation"` | IDS-006 | Module 14 |

**Purpose:** records which domain produced a given artifact without requiring a new Framework Contract type per domain — a single, stable schema (Module 02) serves all six domains.

**Consistency:** every module producing a Framework Artifact set this field identically in form (a single character scalar) across all 15 modules; no module omitted it once an artifact-producing module was introduced (Module 04 onward).

**Domain progression:** the taxonomy's six values trace the project's IDS-002 → IDS-006 domain sequence exactly, with no gaps and no reordering — confirmed at the Clinical Translation Checkpoint as the completion of this progression.

This taxonomy is not modified by this document, consistent with the Strategist's repeated guidance (at the Modeling, Validation, and Interpretation Checkpoints) that formal Governance inclusion be deferred until exactly this synthesis step.

---

# Section 7 — `artifact_role` Taxonomy

`metadata$artifact_role` is the secondary context tag distinguishing multiple artifact types that share one `framework_layer`, introduced at Module 08 (the first domain requiring more than one artifact type per layer) and extended at every subsequent artifact-producing module.

**Complete taxonomy (nine values):**

| `artifact_role` value | `framework_layer` | Module |
|---|---|---|
| `"model_candidate"` | `"modeling"` | 08 |
| `"modeling_evidence"` | `"modeling"` | 08 |
| `"validation_evidence"` | `"validation_benchmark"` | 09 |
| `"benchmark_evidence"` | `"validation_benchmark"` | 10 |
| `"validated_candidate"` | `"validation_benchmark"` | 11 |
| `"interpretation_evidence"` | `"interpretability"` | 12 |
| `"interpretation_package"` | `"interpretability"` | 13 |
| `"clinical_translation_evidence"` | `"clinical_translation"` | 14 |
| `"clinical_translation_package"` | `"clinical_translation"` | 15 |

**Contractual responsibilities:** each value identifies the producing module's single, designated artifact type; no two modules ever produced artifacts sharing the same `artifact_role` value, and no module produced more than one `artifact_role` value (Module 08 is the sole exception by design, producing exactly two sibling roles within one call, per its Architectural Decisions).

**Downstream relationships:** `artifact_role` values within one `framework_layer` are siblings, not a hierarchy — Module 08's Model Candidate and Modeling Evidence are independent and do not embed each other (AD-04); the same independence holds for every subsequent layer that introduced multiple roles.

**Implementation/Framework separation:** `artifact_role` is exclusively a Framework Artifact concept; Implementation Objects (Section 3) carry no equivalent tag, since they never cross a domain boundary and therefore need no inter-domain disambiguation.

No additional role is introduced by this document.

---

# Section 8 — Verified Design Principles

The following principles were not merely specified but directly demonstrated by completed implementation and verified by automated tests across the Coding Phase:

- **Zero/Generic Implementation Principle.** Every default callback (Section 5) performs only structural checks; no module embeds real statistical, biological, or clinical computation. Verified by a dedicated test per module asserting the generic-only disclaiming text.
- **Additive-only Principle.** No Coding Module ever modified a file belonging to a previously LOCKED module. Verified implicitly by every module's unchanged prior test suite continuing to pass cumulatively (e.g. 781 passing assertions at Module 15, none regressed from any earlier module).
- **Stable Public API.** No exported function's name, parameter semantics, or return structure changed after its introducing module's LOCK. Verified by dedicated namespace-export tests at multiple modules confirming the exact expected export set, no more and no fewer.
- **Callback Extensibility.** Every Executor's default behavior is replaceable via a single named parameter without altering workflow, verification, lineage, or artifact construction. Verified by dedicated "custom callback" tests at every Workflow/Executor module (07, 09–15).
- **One-hop Artifact Consumption.** Every domain-execution module consumes exactly one immediately-upstream Framework Artifact type, never reaching further upstream directly. Verified by each module's own "SHALL NOT directly consume" constraint and confirmed architecturally sound by the Strategist at the Validation Checkpoint (assessed as "one of the framework's strongest design choices") and reaffirmed at the Interpretation Checkpoint.
- **Read-only Upstream Artifacts.** Every consumed Framework Artifact is verified unchanged (`identical()` against an independent copy) after being embedded in a downstream Implementation Object or Framework Artifact. Verified by a dedicated immutability test at every consuming module.
- **Workflow Separation.** Orchestration (validation, dependency resolution, object construction) and execution (callback invocation) are never merged into one function. First established explicitly at the Module 03/04 boundary (Discovery), then unified per-module from Module 09 onward.
- **Implementation/Framework Separation.** Implementation Objects (Section 3) and Framework Artifacts (Section 4) are never the same object and never interchangeable; an Implementation Object is never returned where a Framework Artifact is expected, and vice versa. Verified by dedicated "is not exposed as a Framework artifact" tests at every module introducing an Implementation Object.
- **Complete Lineage Preservation.** Every Framework Artifact embeds its complete upstream Implementation Object (and, transitively, every prior artifact), with no information loss. Verified by a single, automated end-to-end test at Module 15 tracing the original Module 04 Discovery artifact through all 13 subsequent modules to the final Clinical Translation Package.

No principle beyond this list is claimed; none were merely aspirational — each is backed by at least one passing, named automated test traceable to a specific module's test suite.

---

# Section 9 — Retrospective Design Lessons

The following are retrospective observations drawn from completed implementation. **They are not Governance. They do not modify Framework rules.** They are recorded here as lessons that may inform, but do not bind, future work.

**Object Maturity Principle (retrospective design lesson only; NOT Governance; does NOT modify Framework rules).** Across the Coding Phase, an Implementation Object's internal schema converged on an identical four-field shape once a module's domain reached its second LOCKed module in the Workflow/Executor pattern (Section 2): one embedded upstream artifact, one `*_components` list, one `execution_metadata` list, one generic `metadata` list. This convergence was not planned in advance for each new domain — it emerged independently at Modules 09, 10, 11, 12, 13, 14, and 15, each arrived at via its own Coding Prompt Consistency Check rather than by explicit copying. The lesson: once a structural pattern proves stable across two or more independent domains, treating it as a default starting template for the next domain (rather than re-deriving it from first principles) measurably reduced the number of Consistency Check clarifications required per module (Modules 09 and 10 required clarifications on naming conventions; Modules 12–15, applying the by-then-mature pattern, required fewer, more narrowly scoped clarifications).

**Additional retrospective observations directly supported by completed implementation:**

- **Anti-duplication via direct reuse.** From Module 09 onward, every module reused its immediately-upstream module's exported (or, in one documented case, internal) validator function directly rather than reimplementing equivalent structural checks. This was explicitly confirmed by the Strategist at multiple Module Reviews as fulfilling, rather than violating, the anti-duplication constraint, and reduced the surface area of new validation logic introduced per module to a single new artifact's structural rules.
- **Consistency Check as a lightweight alternative to Pre-Implementation Decision Records.** Early phases (Modules 03, 04) required formal Pre-Implementation Decision Records to resolve Prompt/LOCKED-architecture conflicts. From Module 06 onward, the lighter-weight "Coding Prompt Consistency Check" — confirming no conflict, with at most one or two narrowly-scoped clarifications — proved sufficient for every subsequent module, including all of Modules 09–15. No module after Module 05 required a full Pre-Implementation Decision Record.
- **Workflow evolution did not require Governance changes.** Two operational workflow changes occurred during the Coding Phase — "Strategist-direct" review (Project Coordinator engaging the Strategist directly, beginning at Module 10) and "new-files-only" packaging (beginning at Module 12) — both confirmed by the Strategist as mature Operational SOPs requiring no Governance update, demonstrating that the locked governance framework accommodated workflow refinement without modification.

---

# Section 10 — Relationship Between Documentation Layers

```
Modules

↓

Strategist Reviews

↓

Checkpoints

↓

Coding Framework Integration
```

**Modules are implementation history.** Each `Execution/Module_XX/` directory (`Prompt.md`, `Artifacts.md`, `Execution_Log.md`, `Review.md`, `LOCK.md`) is the immutable, dated record of what was specified, built, tested, and approved for one Coding Module. It answers: *what happened, and when.*

**Reviews verify implementation quality.** Each Module's `Review.md` is the Strategist's independent verification that one module's implementation satisfies Governance, IDS compliance, architecture, API, and testing requirements at the time of that module's LOCK. It answers: *was this module done correctly, in isolation.*

**Checkpoints synthesize completed phases.** Each of the five Checkpoints (Discovery, Modeling, Validation, Interpretation, Clinical Translation) aggregates evidence across a phase's modules (typically two to three) against five fixed criteria — module completion, contract compliance, artifact integrity, lineage preservation, downstream readiness — and asks questions only visible at the multi-module level (e.g. whether a convention introduced in one module remains sound when a sibling module extends it). It answers: *does this completed phase hold together as a coherent whole.*

**Coding Framework Integration is the canonical synthesis of the entire Coding Phase.** This document is the only artifact that spans all 15 modules and all five Checkpoints simultaneously. It does not re-verify what Reviews and Checkpoints already verified; it identifies and names the recurring patterns (execution architecture, object/artifact hierarchies, callback architecture, the two taxonomies, verified principles) that only become visible once the complete Coding Phase is viewed as a single body of work. It answers: *what did the Coding Phase, as a whole, actually build.*

Each layer is authoritative for its own question and is not superseded by the layers above it: this document does not override any Module Review or Checkpoint verdict, and introduces no new verification of its own beyond what those layers already established.

---

# Section 11 — Overall Assessment

**Architectural maturity.** The Coding Phase converged on one execution architecture (Section 2), applied without exception across seven consecutive Workflow/Executor modules (09–15), and on two stable, consistent context-tagging taxonomies (Sections 6–7) spanning all six IDS domains. No architectural alternative was introduced or entertained after Module 09; no Checkpoint identified architectural drift.

**Implementation consistency.** Across 15 modules, zero LOCKED files were ever modified by a later module; zero exported APIs changed semantics after LOCK; the package's cumulative test suite grew monotonically from 1 assertion (Module 01) to 781 assertions (Module 15) with zero regressions at any point, confirmed by `devtools::check()` reporting 0 errors and 0 warnings at every module from Module 02 onward.

**Framework readiness.** The complete artifact lineage (Section 4), the complete callback surface (Section 5), and the complete taxonomy pair (Sections 6–7) together constitute a generic scaffold spanning the full biomarker-discovery lifecycle, with every extension point (callback parameters) already in place and already exercised by tests using non-trivial example callbacks. No real methodology is embedded anywhere, by design, per the Zero/Generic Implementation Principle (Section 8) — the framework is structurally complete and methodologically empty, exactly as specified.

**Downstream readiness.** Clinical Translation Package (Module 15) is the terminal, stable Framework Artifact of the Coding Phase, with a documented default consumer (`"framework_integration"`) and a complete, automated, end-to-end lineage trace back to the original Discovery artifact. No further Coding Module is required to make this artifact usable; any future work (real methodology, clinical-facing reporting, publication) may proceed by supplying callbacks to already-LOCKED functions or by consuming Clinical Translation Package as a stable, documented input.

This document proposes no implementation change. The Coding Phase, as synthesized above, is complete.

---

End of CODING_FRAMEWORK_INTEGRATION.md.

---

**Status: ACCEPTED — Project Coordinator confirmed, 2026-06-29. No further revisions. This document is the final, canonical synthesis of the Coding Phase (Modules 01–15).**
